GENOMIC EVOLUTION AND RESISTANCE TO PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR PRE-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: RESULTS FROM THE PHASE I/II BRUIN STUDY
JR Browna, JA Woyachb, K Patelc, TA Eyred, Cy Cheahe,f, P Ghiag, W Jurczakh, P Abadai, WG Wierdaj, GFPN Presenterk
a Dana-Farber Cancer Institute and Harvard Medical School, Boston, United States
b The Ohio State University Comprehensive Cancer Center, Columbus, United States
c Swedish Cancer Institute, Seattle, United States
d Churchill Cancer Center, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
e Linear Clinical Research, Perth, Australia
f Sir Charles Gairdner Hospital, Perth, Australia
g Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy
h Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland
i Loxo@Lilly, Indianapolis, United States
j University of Texas MD Anderson Cancer Center, Houston, United States
k Hospital Israelita Albert Einstein (HIAE), São Paulo, Brazil
Ver másRead
232
Timeswas read the article
123
Total PDF
109
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 May | 19 | 18 | 37 |
| 2024 April | 36 | 21 | 57 |
| 2024 March | 22 | 14 | 36 |
| 2024 February | 10 | 12 | 22 |
| 2024 January | 4 | 4 | 8 |
| 2023 December | 7 | 26 | 33 |
| 2023 November | 8 | 19 | 27 |
| 2023 October | 3 | 9 | 12 |
